EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY-NC-ND 4.0

In vivo CRISPR gene editing in patients with herpetic stromal keratitis

Anji Wei, Di Yin, Zimeng Zhai, Sikai Ling, Huangying Le, Lijia Tian, Jianjiang Xu, Soren R Paludan, Yujia Cai, Jiaxu Hong

Molecular Therapy · 2023-11 · 31 (11) · 3163-3175

DOI: 10.1016/j.ymthe.2023.08.021 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Molecular Therapy, 2023-11. Verfasst von Anji Wei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Science, Eye, and ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Keratitis, Herpetic, Herpesvirus 1, Human. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Shanghai Jiao Tong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In vivo CRISPR gene therapy holds large clinical potential, but the safety and efficacy remain largely unknown. Here, we injected a single dose of herpes simplex virus 1 (HSV-1)-targeting CRISPR formulation in the cornea of three patients with severe refractory herpetic stromal keratitis (HSK) during corneal transplantation. Our study is an investigator-initiated, open-label, single-arm, non-randomized interventional trial at a single center (NCT04560790). We found neither detectable CRISPR-induced off-target cleavages by GUIDE-seq nor systemic adverse events for 18 months on average in all three patients. The HSV-1 remained undetectable during the study. Our preliminary clinical results suggest that in vivo gene editing targeting the HSV-1 genome holds acceptable safety as a potential therapy for HSK.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Keratitis, HerpeticHerpesvirus 1, HumanHumansClustered Regularly Interspaced Short Palindromic RepeatsGene EditingCornea

Stichwörter der Autor:innen

CRISPR-Cas9herpes simplex virusherpetic stromal keratitisin vivo gene editinglentiviral particle

Autor:innen und Institutionen

  • Department of Ophthalmology and Visual Science, Eye, and ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
  • Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
  • BDgene Therapeutics, Shanghai, China.
  • Department of Biomedicine, Aarhus University, Aarhus, Denmark.
  • Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China. Electronic address: yujia.cai@sjtu.edu.cn.
  • Department of Ophthalmology and Visual Science, Eye, and ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Science and Technology Co…

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Shanghai Jiao Tong University

Zitieren

APA

Wei, A., Yin, D., Zhai, Z., Ling, S., Le, H., Tian, L., Xu, J., Paludan, S. R., Cai, Y., & Hong, J. (2023). In vivo CRISPR gene editing in patients with herpetic stromal keratitis. Molecular Therapy, 31(11), 3163-3175. https://doi.org/10.1016/j.ymthe.2023.08.021

Vancouver

Wei A, Yin D, Zhai Z, Ling S, Le H, Tian L, et al. In vivo CRISPR gene editing in patients with herpetic stromal keratitis. Molecular Therapy. 2023;31(11):3163-3175. doi:10.1016/j.ymthe.2023.08.021

BibTeX
@article{Wei2023,
  author = {Wei, Anji and Yin, Di and Zhai, Zimeng and Ling, Sikai and Le, Huangying and Tian, Lijia and Xu, Jianjiang and Paludan, Soren R and Cai, Yujia and Hong, Jiaxu},
  title = {In vivo CRISPR gene editing in patients with herpetic stromal keratitis},
  journal = {Molecular Therapy},
  year = {2023},
  volume = {31},
  number = {11},
  pages = {3163--3175},
  doi = {10.1016/j.ymthe.2023.08.021}
}
Kostenlos starten →